Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Fremont, USA
34790 Ardentech Court
Fremont, CA, 94555
USA

People

CEO
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Chief Scientific Officer
Chief Operations Officer
Chief Business Officer
Chief Medical Officer

Funding

TOTAL $132M
FUNDING TOTAL $132M
Series A, 11/2007
New Enterprise Associates
Nomura Phase4 Ventures
HBM BioVentures
ProQuest Investments
$90M
Series B, 8/2009
Nomura Phase4 Ventures
New Enterprise Associates
HBM BioVentures
ProQuest Investments
$30M
Series B, 3/2010
$9.01M
Partial Close, 8/2010
$3.11M
DEBT TOTAL $10.2M
Debt, 9/2011
$4.71M
Debt, 9/2013
Nomura International
BioMed Ventures
New Enterprise Associates
$3.03M
Debt, 3/2014
$2.5M

Tags

Zosano Pharma

Zosano Pharma is a private pharmaceutical company founded in October 2006 and is focused on creating better products with their innovative drug delivery technology.

Their lead program, parathyroid hormone (PTH) transdermal microprojection delivery system has finalized a Phase 2 clinical trial for treating severe osteoporosis. Zosano’s objective is to discover and develop therapeutic drug candidates which address large unmet medical needs or have a significant potential for commercialization.

Recent Milestones

Videos

Screenshots

Zosano Pharma screenshot
Above: Zosano Pharma
Uploaded: 7/14/09

Sources

  1. Zosano Pharma, Inc. Announces Funding Close Totaling $90 Million (zosanopharma.com) [edit]
  2. Zosano Pharma, Inc.: Series B $30M (onbiovc.com) [edit]
  3. SEC (sec.gov) [edit]
  4. SEC (sec.gov) [edit]
  5. SEC (sec.gov) [edit]
  6. Silicon Valley Venture Capital Almanac source [edit]
  7. SEC (sec.gov) [edit]
Edit This Page
Last Edited 3/6/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy